PT  - JOURNAL ARTICLE
AU  - Zhang, Yonghao
AU  - Ma, Cuidie
AU  - Ding, Rui
AU  - Chen, Han
AU  - Xu, Lida
AU  - Yu, Changyuan
TI  - The ratio of interacting miRNAs’ expressions is a robust biomarker for disease classification in multi-center data
AID  - 10.1101/2023.06.29.23291976
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.06.29.23291976
4099  - http://medrxiv.org/content/early/2023/07/06/2023.06.29.23291976.short
4100  - http://medrxiv.org/content/early/2023/07/06/2023.06.29.23291976.full
AB  - Background Many miRNA-based diagnostic models have been constructed to distinguish diseased individuals. However, due to the inherent differences across different platforms or within multi-center data, the models usually fail in the generalization for medical application.Results Here, we proposed to use the within-sample expression ratios of related miRNA pairs as markers, by utilizing the internal miRNA: miRNA interactions. The ratio of the expression values between each miRNA pair turned out to be more stable cross multiple data source. Moreover, we adopted the genetic algorithm to solve the curse of dimensions when exploring the features.Conclusions The application results on three example datasets demonstrated that the expression ratio of interacting miRNA pair is a promising type of biomarker, which is insensitive to batch effects and has better performance in disease classifications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (Grant number 82174531)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Publicly available datasets were analyzed in this study. This data can be found here: https://portal.gdc.cancer.gov/ and https://www.ncbi.nlm.nih.gov/geo/.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis data can be found here: https://portal.gdc.cancer.gov/ and https://www.ncbi.nlm.nih.gov/geo/. https://portal.gdc.cancer.gov/ https://www.ncbi.nlm.nih.gov/geo/